Advertisement
YOU ARE HERE: LAT HomeCollectionsSloan Kettering Cancer Center
IN THE NEWS

Sloan Kettering Cancer Center

FEATURED ARTICLES
NEWS
April 4, 1997 | From Associated Press
It went from Liz Taylor to photographer Firooz Zahedia, who sent it to Gregory Peck, who sent it to Lauren Bacall, who sent it to Mike Nichols, who sent it to Steve Martin, who . . . By the time all the links in this chain letter were made, Memorial Sloan-Kettering Cancer Center had about $250,000 for a home-care program for terminal patients. Hospital officials took the money, but weren't entirely pleased with the unauthorized effort by volunteer nurse and fund-raiser Carol Farkas.
ARTICLES BY DATE
BUSINESS
December 20, 2007 | From Times Wire Services
Amgen Inc., the world's largest biotechnology company, was sued by Sloan-Kettering Institute for Cancer Research, which claims it has been underpaid by at least $72 million in a licensing agreement over two drugs. The institute, which filed a complaint in federal court in Manhattan, claims Amgen took "impermissible deductions" in a licensing agreement over the drugs Neupogen and Neulasta.
Advertisement
NEWS
October 8, 1999 | MARLENE CIMONS, TIMES STAFF WRITER
Dr. Harold E. Varmus, the only Nobel laureate to head the National Institutes of Health, announced Thursday that he is resigning to become director of the Memorial Sloan-Kettering Cancer Center in New York. Credited with restoring NIH's basic scientific mission and with putting real muscle in its research budget during his six years as director, Varmus urged President Clinton to appoint another scientist to the post--and quickly.
NEWS
October 8, 1999 | MARLENE CIMONS, TIMES STAFF WRITER
Dr. Harold E. Varmus, the only Nobel laureate to head the National Institutes of Health, announced Thursday that he is resigning to become director of the Memorial Sloan-Kettering Cancer Center in New York. Credited with restoring NIH's basic scientific mission and with putting real muscle in its research budget during his six years as director, Varmus urged President Clinton to appoint another scientist to the post--and quickly.
NEWS
December 1, 1988 | ROBERT STEINBROOK, Times Medical Writer
In an article likely to spark controversy, researchers at the prestigious Memorial Sloan-Kettering Cancer Center in New York City have called for curtailed use of aerosol pentamidine, a widespread experimental therapy for a pneumonia that afflicts AIDS patients. "Aerosol pentamidine should not be used for treatment of pneumocystis pneumonia and should be used as (a preventive measure) only in careful clinical trials," Dr.
BUSINESS
December 20, 2007 | From Times Wire Services
Amgen Inc., the world's largest biotechnology company, was sued by Sloan-Kettering Institute for Cancer Research, which claims it has been underpaid by at least $72 million in a licensing agreement over two drugs. The institute, which filed a complaint in federal court in Manhattan, claims Amgen took "impermissible deductions" in a licensing agreement over the drugs Neupogen and Neulasta.
SPORTS
July 4, 1992 | From Staff and Wire Reports
Former North Carolina State basketball coach Jim Valvano is undergoing treatment at Memorial Sloan-Kettering Cancer Center in New York, a hospital spokesman said. Valvano, 46, entered the hospital Thursday, but his condition and the nature of his treatment were not disclosed.
NEWS
February 11, 1990 | Associated Press
The Duchess of York, the former Sarah Ferguson, came to the United States on Saturday to visit her stepfather, who is in a New York City cancer hospital. Hector Barrantes, 51, has been admitted to the Memorial Sloan-Kettering Cancer Center. A spokeswoman declined to comment on the nature of his illness.
HEALTH
March 16, 2009 | Elena Conis
Teas from across the globe are becoming more and more popular in the U.S. One relative newcomer, yerba mate, is attracting fans for its allegedly jitter-free caffeine boost and high antioxidant content. Lab research suggests some potential health benefits from drinking yerba mate, but studies of lifelong yerba mate drinkers in the tea's native South America suggest the brew increases the risk of some cancers -- a fact most marketing campaigns omit.
NEWS
April 4, 1997 | From Associated Press
It went from Liz Taylor to photographer Firooz Zahedia, who sent it to Gregory Peck, who sent it to Lauren Bacall, who sent it to Mike Nichols, who sent it to Steve Martin, who . . . By the time all the links in this chain letter were made, Memorial Sloan-Kettering Cancer Center had about $250,000 for a home-care program for terminal patients. Hospital officials took the money, but weren't entirely pleased with the unauthorized effort by volunteer nurse and fund-raiser Carol Farkas.
NEWS
December 1, 1988 | ROBERT STEINBROOK, Times Medical Writer
In an article likely to spark controversy, researchers at the prestigious Memorial Sloan-Kettering Cancer Center in New York City have called for curtailed use of aerosol pentamidine, a widespread experimental therapy for a pneumonia that afflicts AIDS patients. "Aerosol pentamidine should not be used for treatment of pneumocystis pneumonia and should be used as (a preventive measure) only in careful clinical trials," Dr.
NEWS
August 12, 1988
Dr. Vincent T. DeVita Jr. will resign Sept. 1 as director of the National Cancer Institute to become chief physician at Memorial-Sloan Kettering Cancer Center in New York. DeVita, 53, has been NCI director since 1975 and presided over an unprecedented expansion in the U.S. cancer-research effort. A chemotherapy expert, he is widely regarded as one of the most influential figures in American medical research.
Los Angeles Times Articles
|